In patients with NSCLC, the CT genotype, TT genotype and T allele of visfatin SNP rs61330082 apparently reduced the risk of NSCLC pathogenesis, whereas the CC genotype appeared to increase the risk [19]. This evidence concerns the gene NAMPT and non-small cell lung carcinoma.